|search over 1,000 Venture Capital related sites|
|1.||Alta Partners: Our Team (81%):|
Jean began his venture capital career in 1971 in Paris, France with Sofinnova and started its very successful American subsidiary, Sofinnova Inc. in 1976 in San Francisco. In 1979, he formed Burr, Egan, Deleage & Co., with Craig Burr and William Egan. During the 1980s and 1990s, BEDCO was a promine...
|2.||5AM Ventures - Leadership - Partners (72%):|
Braughm W. Ricke Controller Mr. Ricke joined 5AM Ventures in 2004 and is responsible for the administration, financial reporting, and communication of all 5AM fund activities. Prior to joining 5AM Ventures, Mr. Ricke was Controller for Artiman Ventures, an early-stage information technology venture ...
|3.||Longworth Portfolio Company: EnvoyWorldWide (67%):|
Investment Team: Jim Savage Bill Sheehan Investment Partners: Battery Ventures Sofinnova Partners Location: Bedford, MA Web Site EnvoyWorldWide Organizations use EnvoyWorldWide’s patented notification and message delivery solutions to automate proactive customer interactions, facilitate busine...
|4.||Lucent Venture Partners: Portfolio News - Network Physics (66%):|
Network Physics Secures $25 Million in Second-Round Financing Led by Lucent Venture Partners with VantagePoint Venture Partners PALO ALTO, Calif.--(BUSINESS WIRE)--Mar. 5, 2001--Network Physics Inc., a network infrastructure company dedicated to improving Internet performance through a deep knowled...
|5.||Alta Partners: Our Team (60%):|
Alix has significant experience in venture capital both in early stage and later-stage investing in life sciences companies. Alix began her venture career in 1990 at Sofinnova Ventures, and has been with Alta since 1997. She has been actively involved in the creation of more than 30 life sciences c...
|6.||Venture capital alliances - syndicate firms from ARCH Venture Partners (58%):|
ARCH works with many other venture capital firms and institutional investors who serve as limited partners, co-investors, and sources of feedback for new company ideas. The following is a partial list of companies that have co-invested in ARCH portfolio companies as part of a syndicate. 3M Corporati...
|7.||Globespan Capital Partners (56%):|
March 22, 2004 Ernst & Young: High-tech activity will return to 1999 levels this year Planned investment by foreign venture capital funds in Israeli start-ups could reach hundreds of millions of dollars By Batya Feldman, Globes Online Kost, Forer and Gabbay - Ernst and Young (Israel) chairman Yitzc...
|8.||Labrador Ventures (50%):|
As a seed fund investor, securing high quality investing partners over the life of a company is tremendously important to achieving successful outcomes. The following are some of the leading venture funds who have invested with Labrador over the last 15 years. Advanced Technology Ventures (ATV) Acce...
|9.||EARLYBIRD | Venture Capital (44%):|
Date Portfolio Exit September 2005 Esmertec AG www.esmertec.com IPO (SWX: ESMN) September 2005 Interhyp AG www.interhyp.de IPO (Prime Standard Frankfurt Exchange: IYP) April 2004 Element 5 AG www.element5.com Trade Sale to Digital River, Inc. (NASDAQ: DRIV) September 2003 kiwilogic.com AG www.kiwil...
|10.||EARLYBIRD | Venture Capital (44%):|
Datum Portfolio Exit September 2005 Esmertec AG www.esmertec.com IPO (SWX: ESMN) September 2005 Interhyp AG www.interhyp.de IPO (Prime Standard der Frankfurter B rse: IYP) April 2004 Element 5 AG www.element5.com Verkauf an Digital River, Inc. (NASDAQ: DRIV) September 2003 kiwilogic.com AG www.kiwi...
|11.||5AM Ventures - Company Profile (43%):|
KaloBios and Celscia Therapeutics Announce Merger Merger creates human antibody therapeutics company, combines rapid human antibody generation technology with experienced product R&D team and expands antibody pipeline. PALO ALTO, California -- January 12, 2004 - KaloBios and Celscia Therapeutics ann...
|12.||GBS Venture Partners :: News and Events (42%):|
NEWS Sunshine Heart Quarterly In... Pharmaxis Ltd Announces Glo... CogState Announces Restruct... CogState Signs Agreement to... Enrolment Commenced in Arid... Novasys Medical Announces N... ASX Announcement - Clinica... Bronchitol Cystic Fibrosis ... Cortical Pty Ltd Presents M... CogState Signs Ag...
|13.||EARLYBIRD | Venture Capital (42%):|
Selection Wednesday, October 12, 2005 Earlybird Portfolio Update: Three successful IPOs in two weeks Earlybird s success adds momentum to European venture capital market maturation Thursday, July 1, 2004 Earlybird is participating as largest investor in a $34 Million Investment in ZONARE Medical Sys...
|14.||GreenHills Ventures (40%):|
Investors: Login | Businesses: Submit Plan GreenHills Ventures, LLC., combines extensive advisory experience with strategic initiatives. We focus on providing strong fundamentals to facilitate sound business execution. GreenHills Ventures, LLC., has developed an extensive network of Fortune 1000 co...
|15.||DIAMONDHEAD VENTURES (40%):|
Current News | Portfolio Archive The following articles highlight various Diamondhead Ventures portfolio companies. Reactivity Gatekeeper Simplifies Lockdown of Web Services Behind the XML Firewall Reactivity, Inc. , a leader in delivering instant and sustainable XML Web services security solutions,...
|16.||InterWest Partners - Investing in Information Technology & Life Sciences (40%):|
InterWest News InterWest Releases Portfolio News Portfolio Releases Events Portfolio Releases [ Portfolio Releases - Main ] April 14, 2005 Diatos Named Among the 2005 Red Herring 100 Europe; Biotech Recognized as One of Most Promising Private European & Israeli Startups PARIS, April 14 - PRNewswire ...
|17.||Axiom Ventures / Press Release (38%):|
February 24 , 2005 FOR IMMEDIATE RELEASE ALGORX PHARMACEUTICALS RAISES $65 MILLION IN SERIES C FINANCING LED BY ADVENT INTERNATIONAL Company Also Appoints New Board Member Cranbury, New Jersey - February 24, 2004 - AlgoRx Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announc...
|18.||AXA Private Equity (English) - Primary Funds (35%):|
Home Contact Site Map Search: Go Company Team Direct Funds Market Funds of Funds Primary Funds Secondary Funds Press Visit other AXA sites: please select.. AXA Group AXA IM AXA IM Belgium AXA IM France AXA IM Germany AXA IM Italy AXA IM Luxembourg AXA IM Netherlands AXA IM Spain AXA IM UK AXA Merken...
|19.||GBS Venture Partners :: News and Events (35%):|
Phenomix Closes Series B Financing at $40 Million [24 May 2005 16:38] San Diego, CA Phenomix Corporation, a drug discovery and development company, announced today the closing of a $40 million private placement of its Series B preferred stock, bringing the total amount raised since inception to $65....
|20.||Venture Capital Funds Portfolio Provided by a Leading Venture Capital Firm (35%):|
Expertise Portfolio Team About Us News Life Sciences Networks Semiconductors/Computing Software Exits Portfolio Company Services Life Sciences Portfolio Companies Anaborex Anaborex is an early stage biotechnology company focused on metabolic disease. Founded by Scripps researchers the company is tar...